
Capitainer is developing the next generation of blood cards:
Imagine a future where you wouldn't have to leave your home to provide a blood sample for clinical analysis. A future in which anyone can take a blood sample from themselves at any time and anywhere and send it by mail to the laboratory for analysis. And then you will get a result with higher accuracy than if the sample was taken by trained medical staff in a health center.
That future is now – made possible by state-of-the-art technology from Capitainer.
Our vision: We believe in equal access to health diagnostics for everyone, everywhere!
Our task: We improve health outcomes for all by providing universal precision sampling technologies.

Cyanagen is an Italian biotech company founded in Bologna in 2003 and certified ISO9001:2015 and ISO13485:2016.
The Company’s core business is designing, developing and manufacturing DNA/RNA extraction kits, chemiluminescent substrates and fluorescent antibodies. These products can be used in research in life sciences (RUO) and In Vitro Diagnostics (CE-IVD).
Our key technologies, covered by international patents, achieve outstanding sensitivity and stability performance and ease of use. Cyanagen is one of the world’s leading manufacturers of chemiluminescent substrates for Western blotting and ELISA/CLIA.
Our fluorescent antibodies are for biological analysis, cell imaging, genomics, and proteomics.

Invitek is a global provider of molecular diagnostics products
The full spectrum of workflows: from sample to result
Invitek products are designed for ultimate ease of use and time saving, with a modular system that can be adapted to any laboratory environment. With Invitek Diagnostics, you can streamline your processes and work efficiently from sample collection and extraction to detection and point-of-use. Discover our complete portfolio for:
- food testing
- human and veterinary diagnostics
- genetic testing
- microbiome analysis
- oncology
- life sciences

Molecular Biology Systems is home to NextGenPCR™, an Ultra fast PCR thermal cycler delivering the world’s fastest PCR technology. Based on our patented technology Molecular Biology Systems has managed to build the fastest thermal cycler available worldwide. For some fragments our thermal cycler is even able to perform a full 3 temperature, 30 cycle PCR in as little as 2 minutes. Above all, NextGenPCR™ ultrafast thermal cyclers accept 96-well plates as well as 384-well plates seamlessly.
Decrease your energy costs substantially with the ultra fast PCR thermal cycler
The ultra fast PCR thermal cycler is also a much greener solution, using plates that are 3.9 times lighter, which means using less polypropylene and up to 50 times less energy per PCR reaction. The latter means the lab uses less energy to cool the room. Taken together this leads to an energy efficiency that is well over 50 times better comparing to standard thermal cyclers.

Founded in 2013, TAmiRNA specializes in the analysis of cell-free RNAs (cfRNAs), with a particular focus on microRNAs, to support the development of in-vitro diagnostic assays based on cfRNA signatures. The company’s technologies have enabled the development of several minimally invasive diagnostic tests, including the CE-IVD-certified hepatomiR® assay for evaluating liver function.
TAmiRNA provides comprehensive RNA analysis services for academic and industrial research, encompassing transcriptomic profiling of liquid biopsies, extracellular vesicles (EVs), cells, and tissues. Expertise includes the analysis of both non-coding and messenger RNAs, with optimized workflows tailored to challenging sample types such as formalin-fixed paraffin-embedded (FFPE) tissues, biofluids (serum, plasma, urine, cerebrospinal fluid, saliva), and EVs.
The company’s approach integrates advanced wet-lab methods with customized bioinformatics pipelines, ensuring robust and reproducible data generation. A key strength of TAmiRNA’s service is the provision of expert consultancy and detailed bioinformatics support to deliver high-quality, publication-ready results.